Applied Molecular Transport to Present at Upcoming June 2022 Investor Conferences

SOUTH SAN FRANCISCO, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced its participation in fireside chats at the following investor conferences:

Event: Jefferies Global Healthcare Conference
Presentation Date & Time: Thursday, June 9, 2022, at 8:30 a.m. ET
Location: New York, New York
Presenter: Tahir Mahmood, Ph.D., chief executive officer and co-founder

Event: JMP Securities 2022 Life Sciences Conference
Presentation Date & Time: Wednesday, June 15, 2022, at 1:00 p.m. ET
Location: New York, New York
Presenters: Shawn Cross, president and chief operating officer, and Bittoo Kanwar, M.D., chief medical officer

Live webcasts will be accessible via the Events page of the Applied Molecular Transport website at Archived replays will be available for 30 days following the events.

About Applied Molecular Transport Inc.
AMT is a clinical-stage biopharmaceutical company developing novel oral biologic product candidates, by leveraging its technology platform to design biologic product candidates in patient friendly oral dosage forms. AMT’s product candidates are designed to precisely target the relevant pathophysiology of disease. AMT’s proprietary technology platform is incorporated in its product candidates, exploiting existing natural cellular trafficking pathways to drive the active transport of diverse therapeutic modalities across the IE barrier. Active transport is an efficient mechanism that utilizes the cell’s own machinery to transport materials across the IE barrier.

AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit

Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications

Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors

Aljanae Reynolds
Wheelhouse Life Science Advisors

Primary Logo

Back to news